BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Discovery Laboratories to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation

  June 7, 2012

   · 

  3 min read
• Lone Star Bio

  Precision Therapeutics, Inc. Presents GeneFx®Colon Signature at the American Society of Colon and Rectal Surgery Symposium (ASCRS), the World’s Largest Colorectal Conference

  June 7, 2012

   · 

  1 min read
• Business

  AIBioTech Hires Noted FBI Investigator and Scientist Dr. Scott Decker to Head Up their Security Division

  June 7, 2012

   · 

  1 min read
• Drug Development

  Advaxis, Inc. Completes Enrollment of Cohort 2 in Phase 2 CIN 2/3 Study

  June 7, 2012

   · 

  1 min read
• Business

  Bruker Corporation Appoints Charles F. Wagner, Jr. as Executive Vice President and New Chief Financial Officer

  June 7, 2012

   · 

  1 min read
• Policy

  Nektar Therapeutics (CA) Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain

  June 7, 2012

   · 

  9 min read
• BioMidwest

  Cardinal Health, Inc. Introduces New Technology Enhancements to Help Nuclear Medicine Departments, Imaging Centers Improve Integration, Efficiency

  June 7, 2012

   · 

  4 min read
• Business

  Governor Patrick, Industry Representatives Join Navidea Biopharmaceuticals to Open New Business and Commercialization Facility in Andover, MA

  June 7, 2012

   · 

  4 min read
• Business

  Cantel Medical Reports 62% Increase in Net Income - EPS of $0.30 vs. $0.19 - on 18% Sales Increase for Third Quarter Ended April 30, 2012

  June 7, 2012

   · 

  4 min read
• UCB, Inc. Release: RAPID™-PsA Study Showed That Certolizumab Pegol Improved the Signs and Symptoms of Psoriatic Arthritis

  June 7, 2012

   · 

  19 min read